Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Optimal dosing regimen defined for OCT in dose-finding studies

Oct. 21, 1998

Photoprotective efficacy obtained with topical application of vitamin C

Oct. 21, 1998

Linoladiol cream: a novel approach to treating acne

Oct. 21, 1998

Overview of studies on SDZ-ASM-981, a potential new gold standard in treating atopic dermatitis

Oct. 21, 1998

Licensing opportunity from BTG: 12(R)-HETE formation inhibitor for psoriasis

Oct. 21, 1998

Licensing opportunity from BTG: topically active 5-LO inhibitor for psoriasis

Oct. 21, 1998

Negotiations between Altana and Hyal for licensing Solarase terminated

Oct. 19, 1998

Access signs agreement for amlexanox distribution in four additional markets

Oct. 19, 1998

Successful completion of human safety trials reported for VIMRx wound-healing agent

Oct. 14, 1998

Access signs more agreements for distribution of amlexanox

Oct. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...